BSE · NORRIS

Norris Medicines Ltd.

Sector: Healthcare · ISIN: INE744C01029

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,173

of 5,004 stocks

▼ 191W

Peak #4,154 · 21 Sep 2026

Norris Medicines Ltd., a microcap Healthcare business, is growing revenue modestly, trades at a moderate earnings multiple, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap

17.02 Cr

P/E Ratio

13.83

P/B Ratio

—

ROE

8.32%

ROCE

-20.18%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q3 2025-26	Q1 2025-26	Q4 2024-25
Revenue	92.49 L	3.27 Cr	1.46 Cr	2.72 Cr
Net Profit	-39.68 L	69.74 L	-31.04 L	-22.85 L
EPS	0.80	0.70	0.62	0.23
Operating Profit	-39.67 L	82.33 L	-19.89 L	-2.36 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

34.01%

Public

65.99%

PUBLIC BREAKDOWN

DII

0.07%

MF (within DII)

0.01%

Individuals

21.16%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
22 Aug 2013	Other	Consolidation of Shares
22 Aug 2013	Other	Reduction of Capital

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs